Healthcare Web Wire

Author: Elena Morales

  • 3D-Printed Medical Devices Market Growth and Key Companies Analysis (2023 – 2032)

    3D-Printed Medical Devices Market Growth and Key Companies Analysis (2023 – 2032)

    3D-Printed Medical Devices Market Analysis and Key Players Report (2023 – 2032)

    The 3D-printed medical devices market is anticipated to grow significantly, expanding from USD 3.41 billion in 2022 to approximately USD 17.76 billion by 2032, driven by a projected compound annual growth rate (CAGR) of 17.94% from 2023 to 2032. This rapid growth is largely due to the increasing demand for personalized 3D-printed medical solutions, as advancements in technology make it easier to create custom devices tailored to individual patient needs.

    3D-Printed Medical Devices Market Size 2023 - 2032

     

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5072

    Strict Regulatory Requirements Slow Market Growth

    The FDA’s Center for Devices and Radiological Health regulates 3D-printed medical devices, classifying them under strict regulatory controls as outlined in the FD&C Act and Title 21 of the CFR. Companies producing these devices must register with the FDA and list their products. However, the FDA offers a custom device exemption, allowing certain unique devices—like those for specific, untreated medical conditions—to bypass standard premarket submissions, provided they meet strict criteria, such as an annual limit of five units. In 2017, the FDA issued guidance on application requirements for patient-specific 3D-printed devices, including items like joint replacements and cranial implants.

    Key Companies in the 3D-Printed Medical Devices Market

    1. 3T RPD Ltd.
      3T RPD Ltd. is a leading provider of 3D printing solutions, specializing in the design, development, and production of high-quality customized medical devices and implants. The company focuses on producing complex, patient-specific medical solutions for a variety of healthcare applications, including orthopedics, dentistry, and cranial implants.
    2. Renishaw plc.
      Renishaw plc. is a global engineering company with a strong presence in the 3D printing market, offering advanced additive manufacturing solutions for healthcare. The company specializes in creating precision medical devices, such as surgical tools, implants, and diagnostic devices, utilizing its cutting-edge 3D printing technologies.
    3. Concept Laser GmbH
      Concept Laser GmbH, now part of GE Additive, is a leader in metal 3D printing for the medical industry. It focuses on using its laser-based technology to produce highly accurate and durable metal implants and prosthetics. Concept Laser is recognized for its contributions to the production of custom-tailored medical solutions.
    4. General Electric (GE)
      General Electric (GE) is a major player in the 3D printing space through its GE Additive division. GE develops and manufactures 3D printing systems and materials that are widely used in the healthcare sector to create customized medical devices, including implants and surgical tools, improving patient outcomes.
    5. Arcam AB
      Acquired by GE Additive, Arcam AB specializes in electron beam melting (EBM) technology, which is used to produce high-precision, metal-based 3D-printed medical devices. Arcam’s solutions are primarily used in orthopedics and dental implants, allowing for the creation of customized, high-strength devices.
    6. EOS GmbH Electro Optical Systems
      EOS GmbH is a leading provider of industrial 3D printing systems, offering solutions for both metal and plastic medical devices. The company’s technology enables the production of high-quality, patient-specific implants, surgical instruments, and prosthetics, playing a crucial role in the medical device industry.
    7. Materialise
      Materialise is a global leader in 3D printing, providing comprehensive software and services to the medical sector. The company specializes in developing customized implants, surgical guides, and anatomical models used for preoperative planning. Materialise’s solutions are widely used in orthopedics, dental surgery, and cranial procedures.
    8. EnvisionTEC, Inc.
      EnvisionTEC, Inc. is a key player in the 3D printing industry, offering advanced, high-resolution printing technologies tailored to the medical field. The company is renowned for its work in dental, orthopedic, and hearing aid applications, producing highly detailed and precise 3D-printed medical devices for healthcare professionals.
    9. 3D Systems, Inc.
      3D Systems, Inc. is a leading provider of 3D printing technology and solutions for the medical industry. The company’s products include custom medical devices such as surgical guides, patient-specific implants, and anatomical models used for planning and simulation of surgeries. 3D Systems also offers a range of bioprinting solutions for tissue engineering.
    10. Stratasys Ltd.
      Stratasys Ltd. is a pioneer in 3D printing technologies and offers advanced solutions for the medical sector. The company’s additive manufacturing systems are used to produce a wide range of medical devices, including prototypes, surgical tools, implants, and patient-specific solutions, improving treatment precision and outcomes.
    11. Cyfuse Biomedical K.K.
      Cyfuse Biomedical K.K., a Japanese company, focuses on 3D bioprinting technology to create complex tissue structures. Cyfuse specializes in regenerating human tissues for medical applications, including regenerative medicine and organ reconstruction, advancing the medical field with groundbreaking tissue engineering technologies.
    12. Organovo Holdings, Inc.
      Organovo Holdings, Inc. is a leader in the field of 3D bioprinting, particularly known for creating 3D-printed human tissue models. These models are used for drug testing, disease research, and therapeutic applications, allowing for more accurate testing and personalized treatments in medical research and clinical trials.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/3d-printed-medical-devices-market

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5072

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

  • Regenerative Medicine Market Key Growth Drivers and Leading Players

    Regenerative Medicine Market Growth and Key Developments

    The regenerative medicine market is set for significant growth, projected to increase from USD 14.34 billion in 2022 to over USD 95 billion by 2032, with an impressive compound annual growth rate (CAGR) of 21.4% from 2023 to 2032. This expansion is largely fueled by a growing demand for cell and gene therapies that offer new hope for treating a range of conditions.

    3 Amazing Benefits of Regenerative Medicine: Bahri Orthopedics & Sports Medicine Clinic: Orthopedic Surgeons

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5092

    Key Insights:

    • North America leads the regenerative medicine market, holding a market share of approximately 49.21%.
    • The wound care application segment is anticipated to grow the fastest, with a CAGR of 17.3% over the forecast period (2023-2032).
    • Current estimates suggest that regenerative medicine could benefit nearly 1 in 3 Americans, highlighting its transformative potential across various medical needs.

    1. Medtronic

    • Overview: As one of the world’s largest medical device companies, Medtronic is dedicated to improving lives through medical technology.
    • Specialties: Medtronic specializes in spinal cord and neurological treatments, offering devices and therapies for managing spinal injuries, chronic pain, and other neurological conditions.
    • Key Products: Their spinal and biologics division focuses on products that support tissue regeneration, including bone grafts and spinal implants.

    2. Stryker Corporation

    • Overview: Stryker is a global leader in medical technology, focusing on surgical and orthopedic solutions.
    • Specialties: Known for its innovations in trauma and extremities treatment, Stryker develops solutions for bone, joint, and soft tissue repair, and is expanding into regenerative medicine.
    • Key Products: Stryker’s products include bone grafts, orthobiologic materials, and advanced implants designed to promote bone healing and regeneration after trauma.

    3. Zimmer Biomet

    • Overview: Zimmer Biomet specializes in musculoskeletal healthcare, focusing on orthopedic implants and regenerative solutions.
    • Specialties: With a strong emphasis on restoring mobility, Zimmer Biomet offers a range of biologic materials and implants that support joint and bone health.
    • Key Products: The company’s products include allografts, cell-based therapies, and synthetic grafts that encourage tissue healing and regeneration, often used in joint replacement and spine surgeries.

    4. Pfizer Inc.

    • Overview: Known globally for its pharmaceutical innovations, Pfizer also invests in regenerative medicine and gene therapy.
    • Specialties: Pfizer’s research efforts are geared towards rare and genetic diseases, including neurodegenerative disorders where cell and gene therapies hold promise.
    • Key Products: Pfizer is developing gene therapies that aim to treat genetic conditions at the cellular level, a transformative approach that could redefine treatments for patients with rare diseases.

    5. Novartis AG

    • Overview: Novartis is a prominent player in the regenerative medicine space, focusing on gene therapy for rare and complex diseases.
    • Specialties: Novartis is recognized for developing groundbreaking therapies in cell and gene therapy, particularly for blood and immune-related conditions.
    • Key Products: Novartis’s portfolio includes Kymriah, a CAR T-cell therapy for cancer treatment, and ongoing research into other gene-editing solutions for rare genetic diseases.

    6. Bristol-Myers Squibb (BMS)

    • Overview: Bristol-Myers Squibb is a global biopharmaceutical leader advancing cell-based therapies in immunology and oncology.
    • Specialties: BMS focuses on developing innovative cell therapies to treat cancers and immune-related conditions, with emphasis on CAR T-cell therapies.
    • Key Products: BMS acquired Celgene and its CAR T-cell therapies like Breyanzi and Abecma, approved for treating certain blood cancers.

    7. Vertex Pharmaceuticals Incorporated

    • Overview: Vertex Pharmaceuticals is renowned for its focus on genetic therapies, particularly for cystic fibrosis and other rare diseases.
    • Specialties: Vertex is advancing gene editing through partnerships and developing therapies that target the root causes of genetic conditions.
    • Key Products: In partnership with CRISPR Therapeutics, Vertex is pioneering gene-editing therapies such as CTX001 for sickle cell disease and beta-thalassemia.

    8. Gamida Cell

    • Overview: Gamida Cell is an Israeli company focused on cell therapy for hematologic diseases and bone marrow transplants.
    • Specialties: Known for its work in hematopoietic cell transplantation, Gamida is developing therapies that expand donor cells to improve bone marrow transplant outcomes.
    • Key Products: Gamida’s leading product, Omisirge (formerly known as NiCord), is a cell therapy designed to expand cord blood cells for use in transplants for blood cancers and other hematologic conditions.

    9. Ferring Pharmaceuticals

    • Overview: Ferring specializes in regenerative therapies in reproductive health, urology, and gastroenterology.
    • Specialties: Ferring has a strong focus on regenerative solutions that address infertility and other reproductive health issues, alongside tissue regeneration for urological applications.
    • Key Products: Ferring is developing stem-cell-based therapies, including Adstiladrin for treating non-muscle invasive bladder cancer, a product recently approved for certain cancer treatments.

    10. Syngene International Limited

    • Overview: Syngene is a contract research organization (CRO) that provides research and development support for regenerative medicine and biopharmaceuticals.
    • Specialties: Syngene works with pharmaceutical and biotech companies to advance research in cell and gene therapy, helping accelerate clinical development.
    • Key Services: Syngene offers end-to-end services, from discovery to development, for regenerative medicine companies, supporting them in bringing novel therapies to market more efficiently.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/regenerative-medicine-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5092

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

  • Medical Aesthetics Market Key Players and Industry Insights (2023 – 2032)

    Global Medical Aesthetics Market Trends and Manufacturers Analysis (2023 – 2032)

    The global medical aesthetics market was valued at over USD 5.86 billion in 2022 and is projected to grow to more than USD 7.94 billion by 2032, at a compound annual growth rate (CAGR) of 3.29% from 2023 to 2032.

    Medical Aesthetics Market Size 2023 - 2032

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5013

    The adoption of robot-assisted surgeries is reducing costs and offering less invasive treatment options. Medical aesthetics combines healthcare and beauty, offering procedures like skin tightening, laser hair removal, and lip fillers. These treatments have been sought after for centuries, evolving from ancient beauty practices to advanced medical procedures. The market is driven by rising public awareness, technological advancements, and a demand for minimally invasive treatments. However, high costs, limited insurance coverage, and potential risks of certain procedures pose challenges. Opportunities are growing with the rise of medical tourism, medical spas, and an increased focus on physical appearance.

    Key Companies in the Medical Aesthetics Market

    Several leading companies are shaping the medical aesthetics market by offering innovative treatments and devices. Here are some of the key players:

    • Merz Pharma: A global leader in medical aesthetics, Merz Pharma focuses on treatments for skin aging, with a wide range of injectables and dermatological products.
    • Anika Therapeutics, Inc.: Known for its innovative hyaluronic acid-based products, Anika Therapeutics provides solutions for joint and tissue repair, as well as medical aesthetics.
    • Johnson & Johnson Services, Inc.: A major player in healthcare, Johnson & Johnson offers medical aesthetic treatments through its subsidiary, including injectables for wrinkle reduction and volume restoration.
    • AbbVie: With its popular botulinum toxin product, Botox, AbbVie is a major player in the aesthetics market, offering a range of injectables for both therapeutic and cosmetic uses.
    • Lumenis: Specializing in energy-based technologies, Lumenis offers laser devices for a variety of aesthetic procedures, including skin rejuvenation and hair removal.
    • Solta Medical: A key player in the field of non-invasive aesthetic treatments, Solta Medical offers laser and ultrasound technologies for skin tightening and wrinkle reduction.
    • Syneron Candela: Known for its broad portfolio of laser and light-based products, Syneron Candela provides solutions for skin resurfacing, hair removal, and body contouring.
    • Alma Lasers: Alma Lasers focuses on innovative, non-invasive aesthetic treatments, offering a range of technologies for skin rejuvenation, body contouring, and hair removal.
    • Hologic: Known for its advanced laser and light-based technologies, Hologic provides solutions for aesthetic procedures, including body contouring and skin resurfacing.
    • Cutera, Inc.: Specializing in energy-based devices, Cutera offers treatments for skin rejuvenation, acne, and body sculpting using laser and radiofrequency technology.
    • El.En. S.p.A.: A leading manufacturer of laser systems, El.En. offers a range of products for aesthetic treatments, including hair removal, skin resurfacing, and tattoo removal.
    • Medytox, Inc.: Based in South Korea, Medytox focuses on biopharmaceuticals, including botulinum toxin products for facial wrinkles and other aesthetic treatments.
    • Fotona d.o.o: A global leader in laser technology, Fotona offers state-of-the-art lasers for a variety of medical aesthetics treatments, including skin resurfacing and dental aesthetics.
    • Sisram Medical: A leading company in the medical aesthetics sector, Sisram Medical provides a wide range of laser and energy-based technologies for facial and body treatments.
    • Cynosure: Cynosure offers a comprehensive range of aesthetic treatments, including laser systems for skin rejuvenation, hair removal, and body contouring.
    • Galderma: A global dermatology company, Galderma provides a range of injectables and skincare products aimed at enhancing appearance and treating skin conditions.

    Covid Impact on the Aesthetic Medicine Market

    COVID-19 has a potential economic impact and implications on most sectors, including the pharmaceutical and medical device industries. Governments worldwide are now responding to the threat of COVID-19 with all the essential measures, such as social distancing, travel restrictions, and large-scale quarantines, that are anticipated to impact businesses and consumer spending negatively. Many countries had been in lockdown and have suspended trade with other countries, leading to declining market capitalizations of major companies across the world, along with a decline in industrial production and other businesses. Thus, the rising COVID–19 cases are expected to have a short-term impact on surgical rates of cosmetic procedures. The short-term effects on the surgical segment are less prominent. However, the adverse impacts of COVID-19 on the global economy may have significant indirect effects on the surgical segment of the market

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/technological-advancement-in-cosmetic-procedures-boosting-the-medical-aesthetics-market-growth

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5013

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

  • Alopecia Areata Market Trends and Forecast Insights for 2024 – 2032

    Alopecia Areata Market Growth and Future Prospects

    The global market for alopecia areata is projected to expand from USD 3.09 billion in 2023 to approximately USD 6.30 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.6% during the period from 2024 to 2032.

    Alopecia Areata Market Size 2023 - 2032

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5133

    Introduction

    • Research Objective
    • Scope of the Study
    • Definition and Taxonomy

    Research Methodology

    • Research Approach
    • Data Sources
    • Assumptions

    Executive Summary

    • Synopsis
    • Analyst Recommendations

    Market Overview 

    • Market Dynamics
      • Market Drivers
      • Market Restraints
      • Market Opportunities
    • Value Chain Analysis
      • Raw Material Sourcing
      • Manufacturing Process
      • Logistics & Transportation
      • Buyer Preferences
    • Trends
      • Market Trends
      • Technological Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Buyers
      • Threat of Substitute
      • Threat of New Entrants
      • Degree of Competition
    • PESTLE Analysis for 5 Leading Countries
      • Regulatory Framework for Leading Countries/Regions
      • Supply Demand Analysis
      • Production & Consumption Statistics
      • Export Import Statistics
      • Price Trend Analysis

    Global Alopecia Areata Market Assessment

    • Overview
    • Global Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • Global Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • Global Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings
    • Global Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
      • North America
      • Europe
      • Asia Pacific
      • Middle East and Africa
      • South America

    North America Alopecia Areata Market Assessment

    • Overview
    • North America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • North America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • North America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings

    Europe Alopecia Areata Market Assessment

    • Overview
    • Europe Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • Europe Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • Europe Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings

    Asia Pacific Alopecia Areata Market Assessment

    • Overview
    • Asia Pacific Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • Asia Pacific Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • Asia Pacific Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings

    Middle East and Africa Alopecia Areata Market Assessment

    • Overview
    • Middle East and Africa  Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • Middle East and Africa Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • Middle East and Africa Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings

    South America Alopecia Areata Market Assessment

    • Overview
    • South America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
      • Medications
        • Corticosteroids
        • Minoxidil
        • JAK Inhibitors
        • Dupilumab
        • Immunosuppressants
      • Therapies
        • Phototherapy
        • Low-Level Iaser Therapy
        • Other Therapies
    • South America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
      • Oral
      • Topical
      • Injection
    • South America Alopecia Areata Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
      • Hospitals
      • Dermatology Clinics
      • Homecare Settings

    Company Profiles

    • Pfizer Inc.
      • Company Overview
      • Geographic Footprints
      • Financial Performance
      • Product Portfolio
      • SWOT Analysis
      • R&D Efforts
      • Recent Developments & Strategic Collaborations
        • Product Launch/M&A/Technical Collaboration
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Johnson & Johnson Services Inc.
    • Bayer AG
    • Dr. Reddy’s Laboratories Ltd.
    • Viatris Inc.
    • AstraZeneca
    • Abbott Laboratories

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/alopecia-areata-market-sizing

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5133

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

  • Leading Players in the Non-Steroidal Anti-Inflammatory Drugs Market

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Forecast

    The non-steroidal anti-inflammatory drugs (NSAIDs) market is expected to increase significantly, growing from USD 21.01 billion in 2023 to approximately USD 33.55 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% from 2024 to 2032.

    NSAIDs - Non-Steroidal Anti-Inflammatory Drugs : Pain Killer

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5132

    Report Highlights:

    • Arthritis, an inflammatory bone disorder remains the most prevalent target capturing 38% of the market share in 2023.
    • The oral route of administration reigns supreme with a 56% market share in 2023 due to its convenience.
    • Retail pharmacies lead the pack with a commanding 46% market share in 2023.
    • North America leads the way in the NSAIDs market.

    The Centers for Disease Control and Prevention reports roughly 1 in 5 adults in the U.S., around 53.2 million people, have arthritis. It’s more common in women (20.9%) than men (16.3%). Nonsteroidal anti-inflammatory drugs are highly recommended for managing the pain.

    Non-steroidal anti-inflammatory drugs are commonly used to relieve pain, reduce inflammation, and lower fever. They are widely used to treat arthritis, muscle aches, headaches, menstrual cramps, and minor injuries like sprains and strains. NSAIDs block the production of chemicals in the body called prostaglandins, which are responsible for pain and inflammation.

    These medications are often found in over-the-counter forms like ibuprofen (Advil, Motrin), naproxen (Aleve), and prescription-strength versions. NSAIDs are usually available in oral form, but some can be applied topically as creams or gels for localized pain relief.

    Key Companies in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

    Several major companies are shaping the non-steroidal anti-inflammatory drugs (NSAIDs) market, including:

    • Pfizer Inc.: A global leader in the pharmaceutical industry, Pfizer is known for its extensive portfolio of pain management medications, including NSAIDs.
    • Merck & Co., Inc.: Merck is a multinational healthcare company that produces a wide range of NSAIDs used for pain relief and inflammation treatment.
    • Novartis AG: Headquartered in Switzerland, Novartis offers a variety of NSAID products aimed at addressing pain and inflammatory conditions.
    • GlaxoSmithKline Plc: GSK, based in the UK, is a key player in the NSAID market, providing over-the-counter and prescription pain relief medications.
    • Johnson & Johnson Services Inc.: J&J is known for its innovative pharmaceutical solutions, including NSAIDs that help manage pain and reduce inflammation.
    • Bayer AG: This German multinational pharmaceutical and life sciences company produces several well-known NSAID brands.
    • Dr. Reddy’s Laboratories Ltd.: An Indian pharmaceutical company that manufactures and distributes generic NSAIDs, offering affordable pain relief options worldwide.
    • Viatris Inc.: A global healthcare company known for its wide range of generic medications, including NSAIDs for pain and inflammation.
    • AstraZeneca: A leading biopharmaceutical company, AstraZeneca is involved in producing NSAIDs as part of its portfolio for managing pain and related conditions.
    • Abbott Laboratories: Abbott provides a variety of healthcare products, including NSAIDs that are widely used for pain management and inflammation control.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/non-steroidal-anti-inflammatory-drugs-market-sizing

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5132

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

     

  • Health Insurance Market Growth Prospects and Recent Developments

    Health Insurance Market Growth and Developments Report

    The global health insurance market, valued at USD 1.54 trillion in 2022, is expected to reach over USD 3.02 trillion by 2032, growing at a CAGR of 7.4%. This growth is fueled by rising healthcare costs and the increasing demand for extensive coverage.

    What Is a Health Insurance Policy - Meaning, Benefits & Types

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5085

    How AI is Transforming the Health Insurance Industry

    Artificial Intelligence (AI) is revolutionizing the health insurance sector by driving growth and improving operational efficiency. AI technologies such as machine learning and natural language processing are providing innovative solutions that enhance customer experience and streamline insurance operations. AI-powered tools, like chatbots and virtual assistants, offer personalized support, handling a wide range of customer queries—from policy details to claims processing. This reduces the need for human intervention, lowers operational costs, and boosts customer satisfaction.

    AI algorithms can also process vast amounts of data to identify patterns, helping insurers better assess risks and set premiums more accurately. Predictive analytics enables the industry to anticipate future health trends and patient needs, leading to more proactive, preventive care. AI is also a powerful tool in fraud detection, helping insurers spot unusual claims and potential fraud with greater precision.

    Moreover, AI-driven automation of administrative tasks speeds up claims processing, reduces errors, and improves operational efficiency. Overall, the integration of AI in the health insurance market enhances customer experiences while fostering market growth through more informed decision-making and increased operational efficiency.

    The Impact of Limited Awareness on Health Insurance Market Growth

    Limited awareness of health insurance remains a significant barrier to market growth. When individuals are not fully informed about the benefits or necessity of health coverage, they are less likely to seek insurance products. This lack of awareness leads to fewer customers and slower market expansion. Additionally, without understanding the various plans available, many potential policyholders miss out on the best coverage options for their needs, further stalling market growth.

    Furthermore, limited awareness may lead to delayed or skipped preventive healthcare, as individuals may not fully recognize the value of regular check-ups or early interventions. This often results in more serious health issues and higher medical costs down the line, which negatively impacts both insurers and policyholders.

    There is also a general skepticism about the value of healthcare insurance, with some questioning the need to pay premiums. This skepticism can deter potential customers and make it harder for insurance providers to create a competitive, thriving market.

    To tackle this challenge, targeted educational campaigns are essential to raise awareness about the benefits of health insurance, the different plans available, and the importance of proactive healthcare. Greater awareness will not only attract more customers but also help build a healthier, more financially sustainable healthcare system.

    Recent Developments

    • In June 2021, Anthem, Inc. acquired MMM Holdings, Inc., enabling the company to offer Medicaid and Medicare plans in Puerto Rico.
    • In April 2021, Molina Healthcare, Inc. reached an agreement with Cigna Corporation to acquire Cigna’s Medicare and Texas Medicaid plans.
    • In June 2021, Vitality partnered with Samsung UK to integrate Samsung Health into the Vitality Programme, providing participants with additional tools to monitor their health. This partnership allows Android users to earn Vitality points by automatically tracking their daily steps and heart rate activity through Samsung Health.
    • In 2023, Ayushman Bharat (Pradhan Mantri Jan Arogya Yojana) (AB PMJAY) aimed to provide health coverage of up to 5 lakh per family per year for secondary and tertiary care hospitalization.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/health-insurance-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5085

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

     

  • AI in Breast Imaging Market Size, Trends and Future Growth

    Growth and Outlook of the AI in Breast Imaging Market (2024 – 2032)

    The global AI in breast imaging market is expected to expand significantly, growing from USD 480 million in 2022 to over USD 734 million by 2032. This growth is driven by an increasing prevalence of breast cancer and ongoing advancements in imaging technology. With a projected annual growth rate of 3.30% between 2023 and 2032, the sector is poised for continued progress and innovation.

    Artificial Intelligence (AI) in Breast Imaging Market Size 2023 - 2032

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5084

    The growing emphasis on early diagnosis has spurred advancements in medical technologies, particularly in AI-driven breast imaging. AI is playing a crucial role in improving the accuracy and efficiency of breast cancer detection, offering significant benefits to both healthcare professionals and patients.

    Improved Imaging Precision:

    AI algorithms can analyze mammograms and other imaging data with exceptional precision, helping detect potential abnormalities or cancerous lesions at an early stage, which is vital for successful treatment.

    Reducing False Positives:

    One of the key advantages of AI in breast imaging is its ability to reduce false-positive results. This leads to more reliable diagnoses, minimizing unnecessary anxiety and reducing the need for follow-up procedures, ultimately making the healthcare process more efficient for patients.

    Streamlined Screening Process:

    AI-powered automated screening is enhancing the efficiency and speed of breast cancer screenings. This is particularly important as the demand for screening across larger populations continues to grow.

    As awareness of the importance of early breast cancer detection has increased, so has the demand for AI in breast imaging. AI’s integration improves diagnostic accuracy and helps the healthcare system cope with the growing number of breast cancer screenings, contributing to the market’s overall growth.

    Transformative Potential of AI in Healthcare

    AI’s integration into breast imaging is opening up exciting opportunities for healthcare. According to a 2021 article from the National Institutes of Health, over 20 FDA-approved AI applications for breast imaging have been introduced, though their full potential hasn’t yet been realized. AI offers significant opportunities in various aspects of breast cancer screening, such as breast density measurement, enhancing workflow, assessing treatment responses, and improving image quality.

    The push for early detection of breast cancer is fueled by advancements in treatment, heightened public awareness, and improved screening techniques. However, although biomarkers like DNA, RNA, and proteins offer insight into breast cancer, their global applicability remains limited due to non-reproducibility. Thus, awareness and accessible screening programs remain the most effective means of prevention, especially for individuals at higher risk, who can benefit from clinical consultations and counseling.

    Innovation and Collaboration Driving Growth

    The growth of AI in breast imaging is also being driven by collaboration between key players in the healthcare and technology sectors. Strategic partnerships are playing a pivotal role in advancing diagnostic capabilities and in the ongoing fight against breast cancer.

    In November 2022, Google Health partnered with CAD, Inc. to integrate its AI technology into CAD’s breast imaging solutions. This collaboration aimed to enhance breast cancer detection accuracy and improve screening accessibility worldwide. Similarly, in September 2023, Healthyr teamed up with Koning Health to offer innovative, non-invasive at-home breast health tests, empowering women globally with advanced imaging technology. Another significant partnership took place in October 2023 when Medicom Technologies Inc. collaborated with Onsite Women’s Health to improve the breast cancer detection process through better medical image exchange.

    Recent Technological Advancements

    There have been notable recent advancements in breast imaging technology. In September 2023, Siemens launched the Mammomat B Brilliant Presentation, which uses wide-angle tomosynthesis for faster 3D imaging, offering high accuracy in detecting abnormalities and microcalcifications in just five seconds. Similarly, Hologic and Bayer announced a partnership in September 2023 to provide a comprehensive contrast-enhanced mammography package, further enhancing breast imaging capabilities. Additionally, Abdul Latif Jameel Health entered into a distribution agreement with Sona Health in January 2023 to introduce Sona Health’s Atusa scanner, a portable ultrasound device equipped with AI for enhanced breast health assessments.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/ai-in-breast-imaging-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5084

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

     

  • Bionic Eye Market Innovations, Opportunities and Future Outlook

    Bionic Eye Market Growth, Opportunities, and Trends

    The global bionic eye market is expected to grow significantly, increasing from USD 91.98 million in 2022 to over USD 199.97 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.89% from 2023 to 2032. This growth is driven by the rising number of individuals with visual impairments and the continuous advancements in technology within the field.

    Bionic Eye - How It Works | Most Powerful Bionic Eye Ever

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5083

    The Role of Ophthalmic Implants in Vision Restoration

    Ophthalmic implants, which are small devices placed in the eye to deliver medicine locally over time, are becoming an increasingly popular treatment option. As patients seek more convenient and less painful therapies, the demand for these implants is growing. These implants are playing a crucial role in ophthalmology, offering potential treatments for a variety of eye conditions and diseases. Designed to repair or enhance the function of damaged or diseased ocular structures, ophthalmic implants aim to restore or improve vision. They are emerging as a breakthrough in eye care, providing hope to millions affected by vision loss due to various diseases and injuries. Beyond just restoring sight, these implants are helping shape the future of vision restoration.

    Common types of ophthalmic implants include intraocular lenses, orbital implants, retinal implants, glaucoma implants, and corneal implants, among others. These devices can greatly improve patient outcomes by addressing vision impairments. For example, intraocular lenses (IOLs) used in cataract surgeries can restore vision and treat conditions like presbyopia, greatly enhancing the quality of life for patients with these issues. In conditions like glaucoma, ocular implants help manage intraocular pressure and prevent further vision loss, making them an essential part of chronic eye care. The increasing launch of innovative products and the adoption of cutting-edge technology continue to drive market growth in this area.

    For example:

    • In August 2023, Alcon India launched the Clareon Monofocal and Clareon Toric intraocular lenses (IOLs) along with India’s Clareon Monarch IV delivery system, offering one of the most advanced cataract treatments in the market.
    • In March 2021, Johnson & Johnson introduced the Acuvue Oasys Multifocal with Pupil Optimized Design, which improves vision correction and comfort by combining the company’s innovative Acuvue material with a special design that adapts to the pupil.

    The increasing prevalence of eye diseases like cataracts, glaucoma, and age-related macular degeneration (AMD) is fueling the demand for ophthalmic implants. The aging population and growing awareness of these conditions are contributing to the expansion of the market. Additionally, the shift towards personalized treatments is encouraging the development of custom-made implants tailored to individual patient needs and unique eye anatomy.

    The Bionic Eye A New Era in Vision Restoration

    The bionic eye, an advanced electrical prosthetic surgically implanted into the eye, helps restore light perception in individuals with severe retinal damage. It consists of an external camera, transmitter, and an internal microprocessor. The camera is typically mounted on glasses, where it captures environmental visual stimuli and converts them into high-frequency radio waves. In 2012, the first bionic eye was implanted in a patient suffering from vision loss due to retinitis pigmentosa. Developed by Bionic Vision Australia, this early model was a groundbreaking achievement in vision restoration. Since then, technological improvements have led to updated versions of the bionic eye, particularly for those affected by retinal diseases like retinitis pigmentosa. The Argus II, one of the most well-known retinal prostheses, was the first bionic eye approved for use in the U.S. and Europe.

    The growing focus on research and development in this field is expected to bring even more promising solutions for those with vision loss, creating significant opportunities for companies in the market. For example, in October 2021, a new device called the IMIE 256 (256 Channel Intelligent Micro Implant Eye) was tested for its safety and effectiveness, comparing it to the Argus II implant. The results showed that the IMIE 256 had improved safety and effectiveness, though more clinical trials with a larger patient sample are needed to confirm these findings.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/bionic-eye-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5083

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

     

  • AI in Precision Medicine Market Trends, Growth and Key Companies

    Artificial Intelligence in Precision Medicine Market Growth, Analysis and Key Players

    The global Artificial Intelligence (AI) in precision medicine market is projected to expand from USD 1.74 billion in 2022 to over USD 16.91 billion by 2032, reflecting a compound annual growth rate (CAGR) of 25.54% from 2023 to 2032. This growth is driven by the increasing prevalence of cancer and the growing demand for personalized healthcare solutions.

    Artificial Intelligence (AI) in Precision Medicine Market Size 2023 - 2032

     

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5080

    The imperative for Early Cancer Detection Drives Surge in Precision Medicine Market Fueled by AI advancement, with 609,820 Deaths in 2023 Reported By National Cancer Society, Spotlighting Urgent Need for advanced Solutions

    The intersection of artificial intelligence(AI) and precision medicine holds the potential to transform healthcare significantly. Precision medicine techniques aim to identify specific patient phenotypes with uncommon responses to treatment or distinct healthcare requirements. AI plays a pivotal role by employing advanced computational processes and interference, allowing the system to derive valuable Insight, enhance reasoning capacity, and facilitate continuous learning. This, in turn, empowers healthcare practitioners in their decision-making processes through augmented intelligence. Recent literature underscores the importance of translation research in exploring the convergence of AI in Precision medicine, particularly those involving the interplay of non-genomic and genomic determinants. Integrating diverse data sources, including patient symptoms, clinical history and lifestyle, will streamline personalized diagnosis and prognostication.

    AI in Precision Medicine Market Companies

    • IBM is a leader in AI, utilizing its Watson Health platform to develop personalized treatment solutions for patients.
    • Microsoft is making strides with its AI and cloud technologies, focusing on transforming healthcare systems and enabling precision medicine.
    • Google through its AI and deep learning technologies, is contributing to advancements in genomics and personalized medicine.
    • NVIDIA provides powerful AI hardware solutions that accelerate research and clinical applications in precision medicine.
    • Illumina is a leader in genomics, using AI to enhance genetic sequencing and develop personalized treatments.
    • Roche integrates AI to improve drug discovery and healthcare services, focusing on personalized care solutions.
    • Johnson & Johnson is leveraging AI to enhance its healthcare offerings, particularly in personalized medicine and diagnostics.
    • GE Healthcare is using AI to improve imaging technology and diagnostic tools, playing a significant role in precision medicine.
    • Intel Corporation develops AI chips that are essential for advancing precision medicine through faster data processing and research.
    • AstraZeneca applies AI technologies to streamline drug development processes and personalize treatments for patients.
    • Sanofi is exploring the potential of AI to enhance drug discovery, genomics, and patient care personalization.
    • Tempus is a technology-driven company focused on precision medicine, using AI to analyze clinical and molecular data to guide treatment decisions.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field –  https://www.towardshealthcare.com/table-of-content/ai-in-precision-medicine-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5080

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

     

  • AI in Ultrasound Imaging Market Size, Innovations and Growth Projections (2024 – 2032)

    AI in Ultrasound Imaging Market Size, Growth, and Key Companies 

    The AI-powered ultrasound imaging market is expected to grow from USD 881.2 million in 2022 to nearly USD 2 billion by 2032, with a CAGR of 8.6%, driven by the rising prevalence of chronic and lifestyle diseases.

    AI-assisted Ultrasound Solutions Show the Path to Better, Smarter Care | ASUS Pressroom

    Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5082

    Rising Global Disease Rates Fuel Demand for AI in Ultrasound Imaging

    The global rise in cardiovascular diseases and digestive disorders is driving the growing demand for AI-powered ultrasound imaging. According to the World Health Organization, heart attacks and strokes account for 85% of global deaths, with cardiovascular diseases causing 17.9 million deaths annually. Additionally, digestive disorders contribute to over 375,000 deaths each year, with a rate of 37.2 deaths per 100,000 people. This widespread prevalence of chronic conditions is pushing hospitals and clinics to seek faster, more accurate diagnostic tools.

    AI-enhanced ultrasound imaging plays a critical role in early detection and timely diagnosis, helping medical professionals identify issues more quickly. As the need for improved medical imaging grows, AI in ultrasound is becoming essential, especially for conditions like cardiovascular diseases, digestive disorders, and gynecological issues. AI acts as an intelligent assistant, improving diagnostic speed and precision, which is key to addressing the global disease burden.

    Notable Developments:

    • See-Mode Technologies (Singapore) received FDA clearance in September 2020 for its innovative vascular ultrasound scanner, utilizing machine learning for advanced carotid artery analysis.
    • Philips Healthcare gained FDA approval in March 2020 for its ultrasound solutions to treat lung and cardiac complications associated with COVID-19.
    • In February 2023, Boston Imaging launched the W10 Elite platform for obstetrics and gynecology, featuring AI tools that enhance the diagnostic process.
    • In 2022, GE Healthcare partnered with Sinopharm to develop medical equipment tailored to meet China’s healthcare needs.

    Key Companies in the AI Ultrasound Imaging Market:

    • Philips Healthcare
      Philips is a global leader in healthcare technology, providing innovative ultrasound systems that incorporate advanced AI capabilities for faster diagnosis and improved image quality. Their ultrasound solutions are widely used in obstetrics, cardiology, and emergency care.
    • Siemens Healthineers
      Siemens Healthineers offers cutting-edge AI-driven ultrasound imaging systems that enhance diagnostic efficiency and accuracy. Their solutions support a variety of clinical applications, including cardiology, obstetrics, and musculoskeletal imaging.
    • Samsung Healthcare
      Samsung’s healthcare division provides ultrasound systems integrated with AI technologies to support early disease detection, particularly in cardiology and obstetrics. Their solutions are known for high-quality imaging and ease of use.
    • Butterfly Network
      Butterfly Network is pioneering in handheld ultrasound devices powered by AI, making diagnostic imaging more accessible in remote and low-resource settings. Their Butterfly iQ+ system leverages AI to provide quick, accurate diagnostics on a mobile platform.
    • GE Healthcare
      A leader in medical imaging technologies, GE Healthcare offers AI-powered ultrasound solutions for a range of medical fields, including cardiology, obstetrics, and oncology. Their advanced systems help healthcare providers deliver timely and accurate diagnoses.
    • DiA Imaging Analysis
      DiA Imaging Analysis specializes in AI-based software for ultrasound imaging, focusing on cardiac and musculoskeletal applications. Their solutions help clinicians improve workflow efficiency and diagnostic accuracy.
    • Qure.ai
      Qure.ai is known for its AI-powered solutions for medical imaging, including ultrasound. Their algorithms are designed to enhance image interpretation, helping radiologists and clinicians detect diseases early, including in critical care settings.
    • Exo Imaging
      Exo Imaging is developing advanced, AI-powered ultrasound systems that offer high-quality imaging in a compact, portable format. Their focus is on making ultrasound imaging more accessible and efficient in clinical environments.
    • Ultrasound AI, Inc.
      Ultrasound AI focuses on the development of AI-driven software tools that enhance the quality and speed of ultrasound diagnostics, particularly for cardiovascular and gynecological applications.

    Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/ai-in-ultrasound-imaging-market-size

    To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5082

    You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

    About Us

    Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

    Visit Dental Specifics: https://www.towardsdental.com

    Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

    For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare